UK | pharmaphorum

UK

News

NICE says no to AZ’s Lynparza for prostate cancer

NHS patients in England will not be able to get access to AstraZeneca’s PARP inhibitor Lynparza if they have BRCA-positive advance prostate cancer, according to draft guidance from NICE.

News

Roche introduces 15-minute nasal COVID test in UK

Roche Diagnostics has launched a 15-minute nasal antigen test for COVID-19 in the UK, and says it has millions of the kits avai

News

Great Britain £50 - fifty pounds sterling notes spead out.

Tribunal maintains Lexon’s £1.2m fine for breaking competiti...

Pharmaceutical wholesaler Lexon (UK) has lost its appeal against a £1.2 million fine in a case that accused it of exchanging commercially sensitive information about prices for nortriptylin

News

MHRA approves Seagen’s oral HER2 drug Tukysa

The UK drugs regulator has approved Seagen’s Tukysa as a third-line treatment for HER2-positive breast cancer, shortly after it was given a green light by the European Commission.

News

UK will start first COVID-19 challenge study “within a month...

Sometime within the next few weeks, young and healthy volunteers will be deliberately exposed to the COVID-19 coronavirus in the UK in what looks set to be the first study of its type world

News

Labour accuses government of cronyism in COVID-19 contracts

The UK government’s massive spending on the coronavirus pandemic response has been “rife with conflicts of interest”, says the opposition Labour Party, and an independent watchdog should be

NICE says no to AZ’s Lynparza for prostate cancer

Roche introduces 15-minute nasal COVID test in UK

Tribunal maintains Lexon’s £1.2m fine for breaking competiti...

MHRA approves Seagen’s oral HER2 drug Tukysa

UK will start first COVID-19 challenge study “within a month...

Labour accuses government of cronyism in COVID-19 contracts

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

UK

Editor's Picks